Curis Inc (CRIS)
NASDAQ · Manufacturing · Biological products, (no diagnostic substances)
CRIS price, last 12 months
Key stats
- Previous close
- $0.6143
- Open
- $0.5919
- Day range
- $0.4600 – $0.6050
- 52-week range
- $0.3250 – $28.40
- Volume
- 1.3M
- Avg volume (20 days)
- 13.4M
- Market cap
- $1.1M
Performance
Technicals and fundamentals
About Curis Inc
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.
- Sector
- Manufacturing
- Industry
- Biological products, (no diagnostic substances)
- Listed on
- NASDAQ
- Market cap
- $1.1M